Capital Fund Management S.A. Moderna, Inc. Call Options Transaction History

Capital Fund Management S.A.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $27 Million - $36.6 Million	-316,700 Reduced 27.11%	851,500 $90.7 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $35.4 Million - $53.1 Million	508,900 Added 77.19%	1,168,200 $116 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $29.4 Million - $38.6 Million	304,700 Added 85.93%	659,300 $68.1 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $32.4 Million - $43.9 Million	273,400 Added 336.7%	354,600 $43.1 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $9.88 Million - $14.3 Million	-72,800 Reduced 47.27%	81,200 $12.5 Million

Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $14.9 Million - $26.5 Million	-126,000 Reduced 45.0%	154,000 $27.7 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $5.6 Million - $9.2 Million	-47,400 Reduced 14.48%	280,000 $33.1 Billion
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $5.52 Million - $8.32 Million	47,100 Added 16.8%	327,400 $46.8 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $5.94 Million - $11 Million	-47,000 Reduced 14.36%	280,300 $48.3 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $7.02 Million - $11.5 Million	31,100 Added 10.5%	327,300 $83.1 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $25.4 Million - $55.5 Million	-114,600 Reduced 27.9%	296,200 $114 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $32.4 Million - $58.6 Million	249,500 Added 154.68%	410,800 $96.5 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $17.6 Million - $30 Million	161,300 New	161,300 $21.1 Million

1,039

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.